SGLT2 Inhibitors – The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative Review
Article in Diabetes Therapy (April 2024)
The most recent citing publications are shown below. View all 92 publications that cite this research output on Dimensions.
Article in Diabetes Therapy (April 2024)
Article in PLOS ONE (March 2024)
Article in Journal of Clinical Medicine (March 2024)